Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
Angela Q. Zhang, Alexander Hostetler, Laura E. Chen, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1113-1128
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
Probiotic-guided CAR-T cells for solid tumor targeting
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 111
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 24
Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review
Aleksandra Golonko, Tomasz Pienkowski, Renata Świsłocka, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 19
Novel strategies to manage CAR-T cell toxicity
Arthur Mulvey, Lionel Trueb, George Coukos, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
The therapeutic potential of immunoengineering for systemic autoimmunity
David A. McBride, Ryan M. Jones, Nunzio Bottini, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 203-215
Closed Access | Times Cited: 9
Surface Engineering of Natural Killer Cells with CD44‐targeting Ligands for Augmented Cancer Immunotherapy
Sungjun Kim, Shujin Li, Ashok Kumar Jangid, et al.
Small (2023) Vol. 20, Iss. 24
Closed Access | Times Cited: 17
Mechanical forces amplify TCR mechanotransduction in T cell activation and function
Nicholas Jeffreys, Joshua M. Brockman, Yunhao Zhai, et al.
Applied Physics Reviews (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Engineering platforms for localized long-acting immune modulation
Corrine Ying Xuan Chua, Dixita Viswanath, David P. Huston, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 153, Iss. 3, pp. 572-575
Open Access | Times Cited: 5
Optimized Design of Hyaluronic Acid–Lipid Conjugate Biomaterial for Augmenting CD44 Recognition of Surface-Engineered NK Cells
Hee Won Park, Wonjeong Lee, Sungjun Kim, et al.
Biomacromolecules (2024) Vol. 25, Iss. 3, pp. 1959-1971
Closed Access | Times Cited: 5
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Weihuan Shao, Yiran Yao, Ludi Yang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy
Zaid Taha, Mathieu J. F. Crupi, Nouf Alluqmani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Enhanced mRNA delivery using ultrasound-delivered click reactive anchors
Emilio Di Ianni, Jueun Jeon, Hui-Yu Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Spatial Control of CAR T Cell Activation Using Tumor-Homing Polymers
Clinton M. Heinze, Trey J. Pichon, Abe Y. Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Liposomal-Based Nanoarchitectonics as Bispecific T Cell Engagers in Neuroblastoma Therapy
Jorge Parra‐Nieto, Laura Hidalgo, Marta Márquez-Cantudo, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Tumor Microenvironment-Responsive Nano-Immunomodulators for Enhancing Chimeric Antigen Receptor-T Cell Therapy in Lung Cancer
Qian Chen, Jie Sun, Sisi Ling, et al.
ACS Nano (2025)
Closed Access
Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
Unravelling the modified T cell receptor through Gen-Next CAR T cell therapy in Glioblastoma: Current status and future challenges
Bhavya Bhutani, Vinay Sharma, Nirmal Kumar Ganguly, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117987-117987
Closed Access
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access
Cell therapies against brain tumors: Clinical development and emerging prospects
Tatsuya Fukuta, Suyog Shaha, Andrés da Silva‐Candal, et al.
Bioengineering & Translational Medicine (2025)
Open Access
SynNotch CAR-T cell, when synthetic biology and immunology meet again
Mohsen Shirzadian, Sepideh Moori, Ramin Rabbani, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells
Laura Volta, Renier Myburgh, Christian Pellegrino, et al.
Leukemia (2024)
Open Access | Times Cited: 3
Ex Vivo Surface Decoration of Phenylboronic Acid onto Natural Killer Cells for Sialic Acid-Mediated Versatile Cancer Cell Targeting
Ashok Kumar Jangid, Sungjun Kim, Hee Won Park, et al.
Biomacromolecules (2023) Vol. 25, Iss. 1, pp. 222-237
Closed Access | Times Cited: 9
Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers
Grace C. Russell, Yassin Hamzaoui, Daniel Rho, et al.
Cytotherapy (2024) Vol. 26, Iss. 8, pp. 842-857
Closed Access | Times Cited: 2
Targeted acidosis mediated delivery of antigenic MHC-binding peptides
Joey J. Kelly, Emily Ankrom, Sarah E. Newkirk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top